home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Soligenix, Inc. - Common Stock (NQ:SNGX)

1.440 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why Carvana Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket ↗

May 05, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 05, 2023

Good morning! We're diving into the biggest pre-market stock movers traders will want to keep an eye on for Friday morning!

Via InvestorPlace

Nasdaq Down 50 Points; ConocoPhillips Posts Upbeat Earnings ↗

May 04, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Thursday. The Dow traded down 1.19% to 33,015.85 while the NASDAQ fell 0.49% to 11,966.96. The S&P...

Via Benzinga

Why Are Soligenix Shares Trading Higher Today ↗

May 04, 2023

Via Benzinga

FDA Asks For Additional Successful Trial To Approve Soligenix's Rare Cancer Candidate ↗

April 14, 2023

Via Benzinga

Why Are Soligenix Shares Plummeting Today? ↗

February 14, 2023

Via Benzinga

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 04, 2023

Via Benzinga

Soligenix (NASDAQ: SNGX) Reports Strong Clinical Results from Compatibility Study of HyBryte as a Treatment for Cutaneous T-Cell Lymphoma

May 04, 2023

Soligenix, Inc. (NASDAQ: SNGX) is engaged as a late-stage biopharmaceutical company that is focused on the research, development and commercialization

Via Spotlight Growth

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 20, 2023

Via Benzinga

This Combination Therapy Could Help Change Cancer Treatment — Benzinga Looks Deeper Into Allarity Therapeutics' Trial, Including An Interview With An Oncology Expert ↗

April 13, 2023

Allarity Therapeutics (NASDAQ: ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drug

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 14, 2023

On Friday, 127 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 11, 2023

On Tuesday, 65 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 10, 2023

Monday's session saw 114 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 28, 2023

During Tuesday, 79 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 27, 2023

During Monday's session, 56 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks

February 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Death

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

Nasdaq Turns Higher; Soligenix Shares Plunge ↗

February 14, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The...

Via Benzinga

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

Crude Oil Down 1%; SkyWater Technology Shares Spike Higher ↗

February 14, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday. The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P...

Via Benzinga

OXY Stock Alert: Occidental Petroleum Receives Goldman Sachs Upgrade ↗

February 14, 2023

Occidental Petroleum (OXY) stock is on the rise Tuesday following an bullish upgrade and new price target from Goldman Sachs.

Via InvestorPlace

Why Is Soligenix (SNGX) Stock Down 35% Today? ↗

February 14, 2023

Soligenix (SNGX) stock is falling hard on Tuesday with heavy trading after the company's HyBryte cancer drug was rejected by the FDA.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

February 14, 2023

During Tuesday, 40 stocks hit new 52-week lows.

Via Benzinga

Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January ↗

February 14, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42%...

Via Benzinga

Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

February 14, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 14, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!

Via InvestorPlace

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com